Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Share-based Compensation (2020 - 2025)

Pulse Biosciences has reported Share-based Compensation over the past 6 years, most recently at $5.0 million for Q4 2025.

  • Quarterly results put Share-based Compensation at $5.0 million for Q4 2025, down 26.84% from a year ago — trailing twelve months through Dec 2025 was $21.5 million (up 57.93% YoY), and the annual figure for FY2025 was $21.5 million, up 57.93%.
  • Share-based Compensation for Q4 2025 was $5.0 million at Pulse Biosciences, down from $5.6 million in the prior quarter.
  • Over the last five years, Share-based Compensation for PLSE hit a ceiling of $6.8 million in Q4 2024 and a floor of $723000.0 in Q3 2022.
  • Median Share-based Compensation over the past 5 years was $2.2 million (2021), compared with a mean of $3.0 million.
  • Biggest five-year swings in Share-based Compensation: plummeted 79.29% in 2022 and later skyrocketed 347.06% in 2023.
  • Pulse Biosciences' Share-based Compensation stood at $3.6 million in 2021, then plummeted by 79.29% to $748000.0 in 2022, then skyrocketed by 347.06% to $3.3 million in 2023, then skyrocketed by 103.14% to $6.8 million in 2024, then fell by 26.84% to $5.0 million in 2025.
  • The last three reported values for Share-based Compensation were $5.0 million (Q4 2025), $5.6 million (Q3 2025), and $5.2 million (Q2 2025) per Business Quant data.